Drug Shortage Report for KIVEXA

Last updated on 2019-03-15 History
Report ID 74011
Drug Identification Number 02269341
Brand name KIVEXA
Common or Proper name abacavir (as abacavir sulfate) and lamivudine tablets
Company Name VIIV HEALTHCARE ULC
Active Ingredient(s) ABACAVIR LAMIVUDINE
Strength(s) 600MG 300MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30's
ATC code J05AR
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-01-25
Estimated end date 2019-03-18
Actual end date 2019-03-14
Shortage status Resolved
Updated date 2019-03-15
Company comments
Health Canada comments
Company contact information 1-877-393-8448

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2019-03-15 English Compare
v6 2019-03-14 French Compare
v5 2019-03-14 English Compare
v4 2019-02-27 French Compare
v3 2019-02-27 English Compare
v2 2019-01-30 French Compare
v1 2019-01-30 English Compare